XML 82 R72.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS – RELATED PARTIES (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 15, 2021
Mar. 12, 2021
Feb. 25, 2021
Jun. 30, 2021
Dec. 31, 2020
Aug. 12, 2021
Jun. 11, 2021
Jun. 04, 2021
Apr. 13, 2021
Mar. 09, 2021
IPO [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Share price $ 5.00                  
Shares, Issued 2,000,000                  
Aggregate public offering $ 10,000,000                  
Unrealized gains on equity securities - related party                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Convertible promissory note aggregate principal amount       $ 50,000            
Avalanche International Corp And Alzamend [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Unrealized gain (loss) on its investment         $ 860,000          
Loan Agreement [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Principal amount               $ 20,000,000 $ 15,000,000  
Recognized a loss on issuance of warrants                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Share price             $ 2.99     $ 1.50
Avalanche International Corp. [Member] | Common Stock [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Unrealized gain (loss) on its investment       $ 30,000            
Closing price of stock       $ 0.45 $ 0.50          
Avalanche International Corp. [Member] | Services Transferred Over Time [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Convertible promissory note aggregate principal amount       $ 1,360,000            
Avalanche International Corp. [Member] | Philou Ventures L L C [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Convertible promissory note aggregate principal amount       $ 1,500,000.0            
Interest rate       12.00%            
Number of warrants purchased       3,010,000            
Conversion price (in dollars per share)       $ 0.50            
Warrant term       5 years            
Avalanche International Corp. [Member] | Philou Ventures L L C [Member] | Ownership [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Ownership percentage       1800.00%            
Unrealized gains on equity securities - related party                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Interest rate       8.00%            
Number of warrants purchased       16,667            
Warrant term       5 years            
Unrealized gain (loss) on its investment       $ 860,000            
Short-term advance       750,000            
Unrealized gains on equity securities - related party | Recognized a loss on issuance of warrants                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Convertible promissory note aggregate principal amount                   $ 800,000
Unrealized gain (loss) on its investment   $ 31,700,000   $ 3,170,000            
Investment in common stock and warrants   $ 10.0                
Description of reamaining funded amount   The remaining $6.0 million will be funded upon Alzamend achieving certain milestones related to the U.S. Food and Drug Administration approval of Alzamend’s Investigational New Drug application and Phase 1a human clinical trials for Alzamend’s lithium based ionic cocrystal therapy, known as AL001                
Description of agreement   Alzamend has agreed to sell up to 6,666,667 shares of its common stock to DP Lending for $10.0 million, or $1.50 per share, and issue to DP Lending warrants to acquire 3,333,334 shares of Alzamend common stock with an exercise price of $3.00 per share                
Fair value of common stock       $ 8.74   $ 3.83       $ 8.74
Ault And Company Inc [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Interest rate     800.00%              
Principal amount     $ 250,000,000,000              
Maturity date     Feb. 25, 2022